Stay updated on Avutometinib + Defactinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib + Defactinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib + Defactinib in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page presents the details of a completed Phase 2 study of avutometinib alone or with defactinib for recurrent KRAS- or BRAF-mutant non-small cell lung cancer. It includes the study design, eligibility requirements, outcomes, investigators, and participating locations.
    Difference
    71%
    Check dated 2026-11-07T13:35:09.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:13:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T15:47:16.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:36:02.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:28:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home button, indicating the study record is inaccessible; this replaces the previously visible study details and metadata.
    Difference
    18%
    Check dated 2026-09-19T18:59:09.000Z thumbnail image

Stay in the know with updates to Avutometinib + Defactinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib + Defactinib in Lung Cancer Clinical Trial page.